- Home
- DMRA vs SHLS Comparison
DMRA vs SHLS Comparison
Compare DMRA & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DMRA | SHLS |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DMRA | SHLS |
|---|---|---|
| Price | $21.40 | $10.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $43.00 | $9.07 |
| AVG Volume (30 Days) | 356.8K | ★ 5.4M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.86 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $475,331,000.00 |
| Revenue This Year | N/A | $26.24 |
| Revenue Next Year | N/A | $11.52 |
| P/E Ratio | ★ N/A | $41.63 |
| Revenue Growth | N/A | ★ 19.07 |
| 52 Week Low | $16.50 | $3.99 |
| 52 Week High | $28.76 | $13.18 |
Technical Indicators
Market Signals| Indicator | DMRA | SHLS |
|---|---|---|
| Relative Strength Index (RSI) | 31.88 | 52.80 |
| Support Level | $16.50 | $8.46 |
| Resistance Level | $26.66 | $11.27 |
| Average True Range (ATR) | 1.61 | 0.89 |
| MACD | -0.37 | 0.03 |
| Stochastic Oscillator | 13.54 | 39.17 |
Price Performance
Historical ComparisonAbout DMRA Damora Therapeutics Inc. Common Stock
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
About SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.